Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

Biosimilar Strategy pivotal to a stronger European Health… 18 April 2024 2024 marks the occasion of the 20th annual biosimilar medicines…
New IQVIA report points to window of opportunity for the EU… 26 October 2023 The EU is currently reviewing its Pharmaceutical Legislation, and the…
Now or never: Europe must seize the Pharma Legislation… 7 November 2023 Medicines for Europe, representing the European value-added medicines industry, is…
PHARMACEUTICAL TECHNOLOGY - Inflation drives pharma… 11 October 2022 Inflation is at an all-time high, opening an opportunity for…